RenovoRx, Inc.

Develops a device platform for delivering targeted therapies directly to solid tumors.

RNXT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 2570 W. EL CAMINO REAL, STE. 320,, 94040 MOUNTAIN VIEW
Website:: https://renovorx.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

RenovoRx, Inc. is a clinical-stage life sciences company developing targeted therapies for solid tumor cancers. The company's proprietary Trans-Arterial Micro-Perfusion (TAMP™) platform utilizes its FDA-cleared RenovoCath® medical device to deliver therapeutic agents directly to the tumor site. This novel approach is designed to increase treatment efficacy and enhance patient safety by potentially minimizing the systemic toxicities associated with standard intravenous chemotherapy. RenovoRx's lead drug-device combination candidate is under evaluation in a pivotal Phase III clinical trial for locally advanced pancreatic cancer. Alongside its therapeutic development, the company is commercializing the RenovoCath device for targeted fluid delivery in the peripheral vascular system.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all RenovoRx, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RenovoRx, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for RenovoRx, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
3-D Matrix,Ltd. Develops peptide-based medical devices for surgical bleeding control and wound healing.	Japan	7777
aap Implantate AG Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.	Germany	AAQ1
ABL Diagnostics Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.	France	ABLD
Adagio Medical Holdings, Inc. Develops ultra-low temp cryoablation catheters for cardiac arrhythmia treatment.	United States of America	ADGM
Advanced Biomed Inc. Develops microfluidic biochips for rapid, affordable liquid biopsy in precision oncology.	United States of America	ADVB
ADVANCED MEDICAL SOLUTIONS GROUP PLC Develops and manufactures innovative tissue-healing technologies for wound care and surgery.	United Kingdom	AMS
AETHLON MEDICAL INC Develops a blood-filtering device to combat resistant cancers and life-threatening viruses.	United States of America	AEMD
Affluent Medical Developing minimally invasive, restorative implants for structural heart disease and urology.	France	AFME
Ainos, Inc. Develops AI-powered 'SmellTech' diagnostics and immune therapies for point-of-care testing.	United States of America	AIMD
AIOBIO Co., Ltd. Develops AI biofluorescence dental tools for early detection of caries and plaque.	South Korea	447690